The prognostic role of CMR using global planimetric criteria in patients with excessive left ventricular

Francesca Macaione1,2, Antonella Meloni1, Vincenzo Positano1

  • 1MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Area della Ricerca S. Cataldo, Via Moruzzi 1, 56124, Pisa, Italy.

European Radiology
|April 6, 2021
PubMed

Insights

Global Grothoff's criteria and myocardial fibrosis predict cardiovascular events in left ventricular non-compaction (LVNC) patients. These findings aid in assessing prognosis and guiding diagnosis confirmation for LVNC using cardiovascular magnetic resonance (CMR).

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac MRI

Background:

  • Cardiovascular magnetic resonance (CMR) is vital for assessing left ventricular non-compaction (LVNC).
  • Current diagnostic criteria for LVNC lack universal acceptance and have limited prognostic data.
  • Prognostic value of CMR findings and specific criteria needs further investigation.

Purpose of the Study:

  • To evaluate the long-term prognostic significance of global Grothoff's criteria.
  • To assess the predictive value of CMR findings for adverse cardiovascular events (CE) in LVNC patients.
  • To determine if planimetric criteria improve LVNC diagnosis and prognosis.

Main Methods:

  • Prospective enrollment of 78 patients with echocardiographic LVNC criteria.
  • Quantification of cardiac function and assessment of Grothoff's criteria using cine CMR images.
  • Detection of myocardial fibrosis via late gadolinium enhancement (LGE) imaging.

Main Results:

  • Petersen's CMR criterion was met by all patients; 26 met global Grothoff's criteria.
  • During a mean 44.2-month follow-up, 28 cardiovascular events occurred, including heart failure and ventricular tachycardia.
  • Multivariate analysis identified positive global Grothoff's criteria (HR=3.33) and myocardial fibrosis (HR=2.41) as independent predictors of CE.

Conclusions:

  • Global Grothoff's criteria and myocardial fibrosis are strong predictors of CE in LVNC diagnosed by CMR.
  • A stepwise approach using global planimetric Grothoff's criteria is recommended for confirming LVNC diagnosis and prognosis.
  • Positive global Grothoff's criteria correlate with increased ventricular arrhythmias in LVNC.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
70
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
126
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
166
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
175
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
138